WORKSHOP
Modeling and targeting cancer
28th October 2016, Cracow
Life Science Park , Congress Hall in Building C/ Free entrance
Programme
09:00 Welcome
09:15 Plenary Lecture: A. Thomas Look – Harvard Medical School, USA
Molecular Pathogenesis and Drug Synergism in a Zebrafish Model of High Risk Neuroblastoma
10:00 Veronika Sexl – University of Veterinary Medicine of Vienna, Austria
CDK6 – a cell cycle kinase goes transcriptional
10:30 Marcin Kortylewski – Medical Research Center, City of Hope, USA
Myeloid cell-selective oligonucleotide inhibitors for treatment of hematologic malignancies
11:00 Coffee
11:20 Richard Moriggl – Ludwig Boltzmann Institute Cancer Research, Austria
Graded pYSTAT5 activation and consequences for leukemia and lymphoma formation
11:50 Iris Behrmann – University of Luxembourg, Luxembourg
Targeting cytokine signals and microRNAs
12:20 Vittorio de Franciscis – Center for Experimental Endocrinology and Oncology, National Research Council, Italy
Aptamers for the selective delivery of anti-STAT-3 therapeutics in tumors
12:50 Lunch
14:30 Marcin Majka – Jagiellonian University Collegium Medicum, Poland
Potential targets for STAT3 mediated therapies
15:00 Anna Cards Figueras – Cardiff University, UK
T-cell activation re-tunes STAT signaling in response to inflammatory cytokines
15:30 Michal Komorowski – Polish Academy of Sciences, Poland
Using mathematical modeling to better understand cellular signalling
16:00 Florian Grebien – Ludwig Boltzmann Institute Cancer Research, Austria
Identification of critical effectors of leukemia oncoproteins using integrated approaches
16:30 Coffee
17:00 Discussion about funding opportunities
17:15 Stefan Grünert – Ludwig Boltzmann Institute Cancer Research, Austria
Funding Opportunities at the European level: from COST to ITN
